Meridian Bioscience, Inc. is a fully-integrated life science company. The Company’s principal businesses are the development, manufacture, sale and distribution of diagnostic test kits, primarily for certain respiratory, gastrointestinal, viral and parasitic infectious diseases; the manufacture and distribution of bulk antigens, antibodies, and reagents used by researchers and other diagnostic manufacturers, and the contract development and manufacture of proteins and other biologicals for use by biopharmaceutical and biotechnology companies engaged in research for new drugs and vaccines. It has three business segments: US Diagnostics, European Diagnostics and Life Science. The Company’s primary source of domestic and international revenues is core diagnostic products, which represented 83% of consolidated net sales during the fiscal year ended September 30, 2008 (fiscal 2008).